tmatsuda@scb.med.kyushu-u.ac.jp (T.M.), kin1@scb.med. kyushu-u.ac.jp (K.N.) In Brief Matsuda et al. report direct neuronal conversion of microglia induced by the expression of a single transcription factor, NeuroD1, which occupies bivalent epigenetic domains for neuronal gene induction. NeuroD1 can also converts microglia into neurons in the adult mouse striatum.
INTRODUCTION
Lineage-specific transcription factors enable the switch from one cell type into another, with potential applications in disease modeling and regenerative therapy (Takahashi and Yamanaka, 2006) . Mouse fibroblasts, for example, have been converted to neurons in vitro by forced expression of the transcription factors Ascl1, Brn2, and Myt1l (Vierbuchen et al., 2010) . In addition to these factors, a neurogenic basic-helix-loop-helix (bHLH) transcription factor, NeuroD1 (ND1), further enhanced the efficiency of direct neuronal conversion from human fibroblasts (Pang et al., 2011) . Cultured mouse astrocytes have also been converted to neurons with a single transcription factor, such as ND1 or Neurog2 (Berninger et al., 2007; Guo et al., 2014; Heinrich et al., 2010) . More recent studies indicate that exogenous Sox2 or ND1 expression converts endogenous astrocytes in the mouse brain and spinal cord to neurons (Brulet et al., 2017; Guo et al., 2014; Niu et al., 2013 Niu et al., , 2015 Su et al., 2014; Wang et al., 2016) . Because glial cells, including astrocytes, proliferate in response to injury in the CNS and eventually form a glial scar (Sofroniew, 2009) , in vivo neuronal conversion from astrocytes raises the possibility of modifying gliotic tissues to provide a cellular source for replenishing impaired neuronal circuits. Microglia, the major immune cells in the CNS, also converge at injured sites and become a predominant cell type within the glial scar (Annunziato et al., 2013; Cregg et al., 2014) . Furthermore, a recent report has shown that, even after selective elimination of most microglia (>99%) in the adult mouse brain, the population can be rapidly replenished from the few surviving microglia (<1%) (Huang et al., 2018) . Thus, microglia that have accumulated at injured sites should be suitable for restoring lost neurons by direct conversion without exhaustion of the source in the brain. Nevertheless, direct conversion of microglia into neurons has not been achieved.
Epigenetic gene regulation, including DNA methylation and histone modifications, modulates chromatin structure and determines the accessibility of target sites to their transcription factors (Goldberg et al., 2007) . Therefore, epigenetic remodeling at cell type-specific gene loci is an important process for the reprogramming of cells. Pioneer factors are defined as a specific class of proteins that penetrate closed chromatin to create accessible binding sites for other proteins, including general transcription factors (Cirillo et al., 2002; Zaret and Carroll, 2011) . During neuronal reprogramming from somatic cells, the pioneer transcription factor Ascl1 occupies closed chromatin and, consequently, enhances neuronal gene expression in the initial phase of reprogramming (Wapinski et al., 2013) . Moreover, the pioneering activity is promoted by small molecules such as forskolin and dorsomorphin in the case of Neurog2-mediated neuronal conversion (Smith et al., 2016) . Although accumulating studies have provided mechanistic explanations for pioneer factormediated induction of specific gene expression in reprogrammed neurons, it remains largely unclear how these factors can simultaneously silence genes that were expressed in the original cells during and/or after neuronal conversion.
Here we report that a single transcription factor, ND1, can directly convert mouse microglia into neurons. ND1-converted neurons express mature neuronal markers and form synaptic networks with primary cultured cortical neurons. To provide mechanistic insights into this conversion, we performed chromatin immunoprecipitation followed by sequencing (ChIP-seq) for ND1 and four histone marks (H3K4me1, trimethylation of histone H3 at lysine 4 [H3K4me3], H3K27me3, and H3K27ac), whole-genome bisulfite sequencing (WGBS), and RNA sequencing (RNA-seq). We found that ND1 penetrated closed chromatin associated with bivalent modifications (H3K4me3 and H3K27me3) to initiate expression of neuronal genes and, consequently, remodeled the chromatin landscape from the bivalent to the monovalent state (H3K4me3). We also observed that the expression of Brn2, a gene directly induced by ND1, supports acquisition of the neuronal gene expression pattern, whereas expression of other ND1 target genes (Scrt1 and Meis2) represses microglial gene expression through the reduction of transcription factors, including Lyl1 and Mafb, which are important for the development and maintenance of immune cells (Bakri et al., 2005; Zohren et al., 2012) . In parallel, ND1 reorganized global DNA methylation and histone modification patterns in microglial promoter and enhancer regions, most likely to suppress microglial identity. These results suggest that ND1 triggers transcriptional and epigenetic changes in microglia as a pioneer factor to confer neuronal identity and erase microglial identity, respectively. Importantly, we indicate that ND1 can convert microglia to striatal projection neuron-like cells in the adult mouse striatum, shedding new light on the development of therapeutic strategies for CNS injury.
RESULTS

Direct Conversion of Microglia into Neurons
To assess whether microglia can be converted into neurons, we first prepared and cultured CD11b-, CD68-, and Iba1-positive microglia in vitro and confirmed that they did not contain bIIItubulin-positive neurons, Nestin-positive neural stem and precursor cells (NS/PCs), glial gibrillary acidic protein (GFAP)-positive astrocytes, or Olig2-positive oligodendrocyte precursor cells, indicating that they were highly enriched microglia (Figures S1A and S1B) . We selected eight transcription factors (Ascl1, Brn2, Myt1l, Olig2, Zic1, Sox2, Neurog2, and ND1), one microRNA (miR124), and one epigenetic factor (MBD3) as candi-dates based on their known roles in reprogramming (Ambasudhan et al., 2011; Brulet et al., 2017; Heinrich et al., 2010; Niu et al., 2013; Pang et al., 2011; Rais et al., 2013; Vierbuchen et al., 2010) . We used lentiviruses encoding each of these factors or short hairpin RNA (shRNA) for MBD3 and expressed them under the control of the doxycycline (Dox)-inducible tetracycline response element (TRE) promoter ( Figures 1A and S1C ). Among these factors, ND1 overexpression showed the highest induction of bIIItubulin-positive cells 6 or 7 days post Dox treatment (dpt) (Figures 1B , S1D, and S1E), although the expression of exogenous ND1 was almost extinguished by 7 dpt ( Figure S1F ). We found that 35% and 25% of ND1-transduced microglia had become bIII-tubulin-positive and Map2ab-positive and bIII-tubulin-negative cells at 7 dpt, respectively, whereas only 13% were Iba1positive (Figures S1G and S1H). Comparable amounts of neuronal marker-positive cells were observed in ND1-transduced microglia that had been activated by stimulation with lipopolysaccharide (LPS) ( Figure S1J ).
To confirm this conversion, we expressed a reverse tetracycline-controlled transactivator (rtTA) under the Iba1 promoter, allowing restricted expression of TRE-controlled genes in microglia ( Figure S2A ). Using this system, we detected bIII-tubulin-, doublecortin (DCX)-and Map2ab-positive cells bearing a neuron-like morphology in ND1-transduced microglia (Figure S2B) . Because the human CD68 promoter has been reported to enable immune cell-specific transgene expression in the mouse , and CD68 is specifically expressed in microglia in the brain, we employed this promoter to further investigate the microglia-neuron conversion. We observed ND1 expression under control of the human CD68 promoter and neuronal marker-positive cells in the transduced microglia (Figures S2C and S2D) , indicating that ND1 can indeed convert microglia to induced neuronal (iN) cells. Next, we sought to determine whether this conversion passes through an NS/PC state. To this end, we cultured microglia with 5-ethynil-2'-deoxyuridine (EdU) throughout the conversion period ( Figure S2E ). Five days after the onset of EdU treatment, the majority of the neuronally converted cells were EdU-negative (Figures S2F and S2G) . In addition, qRT-PCR analysis revealed ND1enhanced mRNA expression of neuronal genes such as Dcx and Tubb3, whereas no change was observed in the expression of NS/PC-related genes (Sox2, Pax6, and Nestin) ( Figure S2H ), suggesting that ND1 converts microglia directly into iN cells with no intermediate NS/PC state. To examine whether these iN cells are glutamatergic or GABAergic, we performed immunostaining with antibodies for VGLUT1 and GAD67 and found that 74.2% of iN cells were positive for VGLUT1 at 21 dpt, whereas 25.7% were stained for GAD67 ( Figures S2I and S2J ).
To explore whether these converted neurons integrate into existing neuronal circuits in vitro, microglia were labeled with tdTomato and converted to iN cells under co-culture with primary cultured neurons ( Figures S3A-S3C ). We found that these fluorescently labeled cells expressed the neuronal marker Map2 together with the mature neuronal marker NeuN and formed excitatory synapses with tdTomato-negative primary cultured neurons (Figures S3D and S3E) . Furthermore, calcium imaging revealed neuronal activity in iN cells in response to N-methyl-D-aspartate (NMDA) stimulation, similar to primary cultured neurons ( Figures S3F-S3H ), suggesting that these iN cells are functional neuron-like cells with the capacity to integrate into existing neuronal circuits. We next performed patch-clamp recordings of iN cells and observed spontaneous action potential firing in iN cells under the current clamp condition ( Figure S3I ). To ensure that these firing responses were indeed action potentials, a depolarization stimulus was given to the soma from the patch pipette, and action potentials could be elicited by depolarizing the membrane ( Figure S3J ); these were completely blocked by tetrodotoxin (TTX) ( Figure S3J ), a specific inhibitor of Na + ion channels. iN cells also exhibited properties similar to neurons in terms of membrane capacity, resting membrane potential, and input resistance ( Figures S3L-S3N ). Moreover, we recorded spontaneous synaptic currents under the voltage-clamp condition at a holding potential of À70 mV and observed them constantly ( Figures S3K, S3O , and S3P). These results indicated that iN cells had been functionally converted to neurons capable of generating action potentials and spontaneous synaptic currents. (D) PCA of neuron-specific genes (left, n = 1,049) and microglia-specific genes (right, n = 1,244) of each sample; microglia day 2 (M day 2), microglia day 7 (M day 7), microglia+ND1 day 2 (M+ND1 day 2), microglia+ND1 day 7 (M+ND1 day 7), neurons, SCR029 cells (NS/PCs), primary cultured NS/PCs (priNS/PCs), oligodendrocytes, and astrocytes. The arrows emphasize the progression of conversion. See also Figure S3 . (E) Heatmap of genome-wide expression analysis during the iN cell reprogramming process by RNAseq across the indicated time points (n = 3 biological replicates). Shown are the 4,325 genes whose expression changed significantly at least 8-fold in ND1-transduced cells (M+ND1 day 7) compared with control microglia (M day 7). (F) Functional annotation of increased and decreased genes in (E). The top five gene ontology (GO) terms in each gene group are displayed.
ND1 Induces Global Transcriptional Changes in Microglia
To gain deeper insight into how ND1 achieves neuronal conversion from microglia, we analyzed the transcriptome of ND1-transduced microglial cultures with a high infection rate (>97%) at 2 and 7 dpt ( Figures 1A,  1B , S3Q, and S3R) and observed a high correlation (r > 0.98, Pearson's correlation) between biological replicates ( Figure 1C ). Notably, global gene expression in ND1-transduced cells at 7 dpt resembles that in primary cultured neurons ( Figure 1C ). To ascertain whether ND1 indeed altered cell identity, we then performed principal-component analysis (PCA). The results indicated that the expression pattern of neuron-specific genes in ND1-transduced cells at 7 dpt is very similar to that in primary cultured neurons, whereas the pattern of microglia-specific genes in these converted cells is distinct from microglia (Figure 1D) , suggesting that forced expression of ND1 provokes and suppresses neuronal and microglial programs, respectively. Furthermore, the expression pattern of neural stem cell (NSC)specific genes in ND1-transduced cells at 2 and 7 dpt was distinct from that of NSCs ( Figure S3S ), further supporting our conclusion that ND1 converts microglia directly into iN cells without their passing through an NS/PC state (Figures S2F-S2H). To substantiate these conclusions, we identified genes whose expression was either increased (n = 2,612) or decreased (n = 1,724) in ND1-transduced cells at 7 dpt relative to microglia transduced with the M2rtTA-expressing virus alone (fold change R 8, q < 0.05) ( Figure 1E ). These genes were subjected to gene ontology analysis of biological processes, which showed that genes induced by ND1 are associated with neuronal development and differentiation ( Figure 1F ). ND1-suppressed genes, on the other hand, were enriched in processes associated with immune responses ( Figure 1F ). Interestingly, it seems that the acquisition of neuronal characteristics had already commenced in ND1-transduced cells at 2 dpt, whereas the loss of microglial properties had barely started by this early time point (Figures 1D and 1E) . These data suggest that ND1 drives activation of the neuronal program prior to suppression of the microglial program during the conversion.
ND1 Directly Binds Regulatory Elements of Neuronal Genes
To find initial targets of ND1 binding, we performed ChIP-seq for ND1 in microglia at 2 dpt, when extensive changes in neuronal gene expression had already been observed (Figures 1D and 1E) , and identified 15,998 significantly ND1-occupied loci using input DNA as a control (Figure 2A ). Approximately 41% of them were annotated within 10 kb from the transcription start site (TSS) of a gene, and 11.6% of such annotated loci neighbored significantly upregulated genes (fold change R 2, q < 0.05) in ND1-transduced microglia at 2 dpt relative to microglia ( Figure 2A ). These ND1-occupied and upregulated genes (hereafter referred to as upregulated genes) were neuronal development-and differentiation-associated genes, such as Bhlhe22 (also known as Bhlhb5) and Brn2 ( Figures 2B and 2C ), suggesting that ND1 directly increases the expression of many of these neuronal genes. Furthermore, exogenous ND1 binds to the endogenous ND1 locus ( Figure 2C ) and induces its own expression, similar to other self-regulatory reprogramming factors, including Neurog2 ( Figure 2D ; Liu et al., 2013) . Interestingly, the expression of genes neighboring 88% of ND1-occupied loci located around a TSS was unchanged (hereafter referred to as unchanged genes) ( Figure 2A ), even though no significant difference between upregulated and unchanged genes was detected regarding ND1 enrichment, distribution around genes, or the identified consensus sequences of ND1-bound regions ( Figures  2E-2G ).
ND1 Preferentially Binds Unmethylated CpG-Rich Regions
To look more closely at ND1 activity around upregulated and unchanged gene loci, we decided to focus on epigenetic modifications, such as DNA methylation and histone modifications. Samples collected from cultured microglial cells before ND1 transduction were subjected to ChIP-seq (H3K4me1, H3K4me3, H3K27ac, and H3K27me3) and WGBS, which enabled us to explore signatures of pre-existing histones and DNA methylation marks in the original microglia ( Figure 1A ). We first analyzed the WGBS data and observed that methylation levels around actual ND1 binding sites in microglia are quite low compared with those around ND1 binding sites predicted by the known ND1 binding motif (CAGCTG) ( Figures 2G, 3A , and 3B). Moreover, the CpG content was higher in regions around actual ND1 binding sites than in regions around predicted ND1 binding sites ( Figure 3C ). These data indicate that ND1 preferentially binds unmethylated CpG-rich regions. However, we did not detect any differences in any of these analyses between upregulated and unchanged genes ( Figures 3D-3F ). Taken together, these data suggest that DNA methylation affects ND1 binding to the genome but is unlikely to contribute to the subsequent gene expression.
ND1 Occupies Bivalent Domains and Induces Neuronal Reprogramming
We then asked whether histone modifications affect ND1 activity. The intensity of pre-existing histone marks in microglia indicated enrichment of active marks (H3K4me3 and H3K27ac) at ND1-bound sites around unchanged genes ( Figure 4A ). In contrast, enrichment of both active and repressive marks (H3K4me3 and H3K27me3, respectively), a configuration described as a bivalent domain, was observed at ND1-bound sites around upregulated genes (Figures 4A and S4A-S4C) whose expression was initially silenced in microglia ( Figure S4D ). We also observed that H3K27me3 accumulates on both sides of the H3K4me3 peak at the ND1-bound sites ( Figure 4A and S4A), consistent with previous observations that target regions of TrxG proteins, which methylate H3K4, display a reduced H3K27 methylation status (Papp and M€ uller, 2006; Srinivasan et al., 2008) because of the fact that active chromatin marks, including H3K4me3, inhibit H3K27me3 modification by PRC2 (Schmitges et al., 2011) . Furthermore, we obtained publicly available data of ATAC-seq (assay for transposase-accessible chromatin with high-throughput sequencing) for microglia (Lavin et al., 2014; Matcovitch-Natan et al., 2016) and applied them to our analyses to determine open or closed chromatin states of ND1-bound sites. The results indicated that ND1-bound sites located around upregulated genes have a relatively closed chromatin status, in accordance with their epigenetic signatures and gene expression levels (Figures 4A, S4D, and S4E). These data indicate that ND1 accesses closed chromatin with bivalent modifications to induce the expression of neuronal development-and differentiation-related genes as a pioneer factor. We also found that unchanged genes associated with active epigenetic signatures were strongly expressed in microglia and exhibited high expression regardless of ND1 binding ( Figure 4A and S4D ). This is probably because unchanged genes were enriched for genes involved in metabolic processes, which are essential for all types of cells ( Figure S4F ). Thus, the bivalent signature predicts permissiveness for ND1 binding and subsequent induction of gene expression.
We next asked whether the presence of a bivalent chromatin state could predict ND1-mediated reprogramming in other glial cell lineages, i.e., astrocytes and oligodendrocytes. We first established mouse astrocytes in vitro and cultured them without growth factors ( Figure S5A ), a condition under which they display properties closely resembling those of non-reactive astrocytes in the physiological state (White et al., 2011) . In accordance with our earlier findings (Brulet et al., 2017) , we observed few Map2ab-positive cells in ND1-transduced non-reactive astrocytes at 7 dpt ( Figures S5B and S5C ). This result is in marked contrast to a previous study in which astrocytes were grown in the presence of epidermal growth factor (EGF) and fibroblast Figure 3 . WGBS Reveals Preferential Binding of ND1 to Unmethylated CpG-Rich Regions (A) Distribution of DNA methylation levels within 2 kb upstream or downstream of actual (green, n = 6,530) and predicted (gray, n = 1,034,549) ND1 binding sites. Predicted ND1 binding sites were identified based on the known ND1 binding motif sequence (CAGCTG) within the whole genome. (B) Average DNA methylation levels in all CpG sites, CpG sites around TSSs (±10 kb), and CpG sites within predicted or actual ND1 binding regions (ND1 binding sites ± 100 bp) located around TSSs (±10 kb). (C) CpG content in the whole genome, TSSs (±10 kb), and predicted or actual ND1 binding regions (ND1 binding sites ± 100 bp) located around TSSs (±10 kb). (D) Distribution of DNA methylation levels around the actual ND1 binding sites (±2 kb) occupied in upregulated (red, n = 764) and unchanged genes (blue, n = 5,735). (E) Average DNA methylation levels in CpG sites within the actual ND1 binding regions (ND1 binding sites ± 100 bp) in upregulated (red) and unchanged (blue) genes. (F) CpG content in the actual ND1 binding regions (ND1 binding sites ± 100 bp) in upregulated (red) and unchanged (blue) genes. growth factor 2 (FGF2) (Guo et al., 2014) . EGF and FGF2 are known to be upregulated in reactive astrocytes in response to injury, and they probably confer a more ''stem-like'' property on astrocytes (Robel et al., 2011) . Oligodendrocytes, on the other hand, were converted into Map2ab and NeuN-positive cells 7 days after ND1 transduction ( Figures S5D-S5I ). By performing ChIP-qPCR analysis in non-reactive astrocytes and oligodendrocytes, we next assessed histone modifications of neuronal genes (Bhlhe22, Prdm8, Brn2, and Pou3f3) , which have been shown to have the bivalent signature (H3K4me3 and H3K27me3) in microglia. As shown in Figures S5J and S5K , we found that the bivalent signature was enriched in these genes in oligodendrocytes but not astrocytes, in accordance with the capacity of ND1 to induce neuronal conversion of these cells. These results provide strong support for the importance of the bivalent chromatin state in ND1-mediated reprogramming.
Although the ND1 expression level became lower in microglia in the later phase of conversion ( Figure S4G ), the expression levels of upregulated genes continued to increase ( Figure S4D ), leading us to hypothesize that epigenetic reprogramming supports the enhancement of gene expression in the neuronal program. To test this, we performed ChIP-seq analysis for H3K27me3 and H3K4me3 in ND1-transduced microglia at 7 dpt (iN cells) and in primary cultured neurons ( Figure 1A ). We observed an increase in H3K4me3 levels in the ND1bound regions around upregulated genes in iN cells compared with microglia ( Figures 4B , 4C, and S4A). In contrast, the levels of H3K27me3 in these regions decreased significantly during conversion. However, although they are morphologically and functionally similar ( Figures S3B-S3P ), the extent of these histone modifications in iN cells did not reach their extent in primary cultured neurons ( Figures 4B and 4C) , perhaps because iN cells may require additional time to gain the same epigenetic profile possessed by neurons or because iN cells may not have an epigenetic profile identical to that of neurons, as observed in the case between induced pluripotent stem cells (iPSCs) and embryonic stem cells .
To investigate how ND1 expression alters the epigenome, we identified differentially expressed genes associated with function in epigenetic modification and chromatin remodeling (n = 171) whose expression levels were significantly changed by ND1 transduction in microglia at 2 dpt (n = 20, q < 0.05, fold change R 1.5) and 7 dpt (n = 87, q < 0.05, fold change R 1.5) (Table S1; Figure S5L ). Among them, we found that ND1 bound to the region around the TSS of Jmjd3, a histone H3K27 demethylase gene, and upregulated its expression ( Figures S5M and  S5N ), suggesting that ND1 resolves bivalent domains to a monovalently marked state during neuronal reprogramming, at least in part because of the direct induction of Jmjd3 expression.
Integrative analysis of our transcriptional and epigenetic data identified 20 transcription factor genes bearing bivalent domains as potential ND1 target genes, which might mediate the iN cell reprogramming process (Table S2) . A literature survey revealed that 14 of these 20 factors potentially play important roles in the generation and maintenance of neurons (Table  S2) . Among these candidates, we selected the top four upregulated transcription factors (Bhlhe22, Prdm8, Myt1l, and Mycn) in addition to one (Brn2) that is known to induce neuronal reprogramming. With the exception of Mycn, individual expression of these genes could induce neuron-like cells ( Figures  4D and 4E ). Combinatorial expression of two genes, Brn2 and Prdm8, further enhanced the conversion from microglia to neuron-like cells (Figures 4D and 4E ). We also found that combinatorial expression of ND1 and Brn2 increased the efficiency of reprogramming mediated by ND1 alone (Figure S5O and S5P). In contrast, when we reduced the expression of Brn2 by shRNAs (sh1 and sh2), the efficiency of ND1-mediated reprogramming was decreased ( Figure S5Q-S5S) . These results suggest that Brn2 acts as an essential ND1 target gene to induce neuronal reprogramming.
Suppression of Microglia-Specific Gene Expression Is Mediated in Part by Direct ND1 Target Genes
Microglial identity was attenuated during iN cell reprogramming through the reduction of immune gene expression ( Figures 1D-1F ). Therefore, we next investigated how ND1 expression accomplishes transcriptional repression of immune genes in microglia. We identified genes persistently downregulated in ND1-transduced cells at 2 dpt and 7 dpt (n = 162) relative to control microglia (fold change % 0.5, q < 0.05) ( Figure 5A ), and these genes included 10 transcription factors. A literature survey further revealed that four of the 10 transcription factors potentially play important roles in development and differentiation of immune cells (Table S3 ). Among these four factors, we selected the top three silenced transcription factors ( Figure 5B ) and designed two distinct shRNAs (sh1 and sh2) for each. Infection of the microglial cell line BV2 with lentiviruses harboring these shRNAs decreased the expression of the candidate factors ( Figure 5C ). In addition, we found that Mafb and Lyl1, but not Batf3 knockdown, resulted in a significant reduction in the expression of immune genes, including Ccl3, Ccl4, Cebpa, Irf8, Pu.1, and p65 in microglia ( Figure 5D and S6A), and combinatorial knockdown of Mafb and Lyl1 caused a further decrease in expression ( Figures 5D and S6A) . To check whether Lyl1 and Mafb could regulate the expression of other immune genes, we analyzed public ChIP-seq data for these transcription factors (Sch€ utte et al., 2016; Soucie et al., 2016) and found that they potentially bind to the pro-moters of silenced genes at both 2 dpt and 7 dpt ( Figure 5E ), including many microglia-specific genes associated with immune functions ( Figure S6B ). These data suggest that Mafb and Lyl1 regulate microglial cell identity through the maintenance of microglial gene expression.
Because ND1 transduction decreased Mafb and Lyl1 expression in microglia even though ND1 is a known transcriptional activator (Figure 2A) , we next investigated whether ND1 induces transcriptional repressors, which subsequently suppress Mafb and Lyl1 expression. We individually expressed five transcriptional repressors among 14 ND1 target genes known to play important roles in the generation and maintenance of neurons (Table S2 ) in microglia and found that Scrt1 and Meis2 bound to the TSS regions of Mafb and Lyl1, leading to their suppression ( Figures 5F and 5G) . Although Myt1l is an important repressive transcription factor for blocking non-neuronal programs in fibroblasts (Mall et al., 2017) , it did not affect the expression of these microglial genes ( Figure 5F ). Nevertheless, these results suggest that ND1 initially induces the expression of neuronal genes, including Scrt1 and Meis2, which subsequently suppress the microglial program by silencing Mafb and Lyl1 expression, supporting the idea that ND1 confers neuronal identity on microglia prior to extinguishing microglial cell identity during reprogramming.
ND1 Induces Epigenetic Reprogramming and Suppresses the Microglial Program
We further investigated whether ND1 induces epigenetic remodeling around microglia-specific genes to suppress microglial identity during neuronal reprogramming. ChIP-seq analysis revealed a significant increase in H3K27me3 and decrease in H3K4me3 levels in the promoters of microglia-specific genes during neuronal reprogramming, although the extent of histone modification did not reach that seen in neurons ( Figure 6A ). By comparing DNA methylation patterns in CNS cells (astrocytes, neurons, oligodendrocytes, and microglia), we next identified microglia-specific hypomethylated sites that potentially shape the profile of microglia-specific gene expression ( Figure 6B ). Approximately 42% of microglia-specific hypomethylated sites were highly methylated (R1.5-fold) in iN cells compared with microglia ( Figure 6C ). Furthermore, these hypermethylated sites were highly enriched in active microglial enhancer regions that were co-occupied by H3K4me1 and H3K27ac ( Figure 6D ). We searched for consensus sequences around the identified hypermethylated sites in iN cells using the algorithm MEME (multiple expectation-maximization [EM] for motif elicitation) , and found that multiple immune-related transcription factors, including Mafb, were enriched around these sites ( Figure 6E ). We also obtained public ChIP-seq data for important immune-related factors from macrophages Langlais et al., 2016; Mancino et al., 2015;  Mené ndez-Gutié rrez et al., 2015; Ng et al., 2011; Ostuni et al., 2013; Soucie et al., 2016) , allowing us to assess the enrichment of these factors in hypermethylated sites in iN cells compared with randomly selected CpG sites ( Figure 6F ). These hypermethylated site-enriched factors include basic leucine zipper domain (bZIP) family (Mafb, Batf3, Cebpa, Junb, and Jdp2) and heat shock transcription factor (HSF) family (HSF1) proteins that predominantly bind to unmethylated CpG-containing sites (Yin et al., 2017) . Taken together, these findings suggest that ND1 reprograms the epigenetic landscape, such as histone modifications and DNA methylation, around promoter and enhancer regions to disrupt the binding of immune-related transcription factors, resulting in suppression of microglial cell identity.
ND1 Can Induce Reprogramming from Microglia to Neurons in the Adult Mouse Brain
Because endogenous adult neurogenesis is insufficient for brain repair, in vivo neuronal reprogramming from endogenous non-neuronal cells is a promising technology to replenish lost neurons. To test whether ND1 is capable of reprogramming microglia into neurons in the adult mouse brain, lentiviral expression of ND1-P2A-EGFP under the promoter of human CD68 was employed to explicitly identify ND1-transduced cells using co-expressed EGFP as the marker. When we injected the lentiviruses into the striatum of 8-week-old mice, approximately 60% of the control virus-infected cells expressed Iba1 together with the microglia-specific marker Tmem119 (Bennett et al., 2016) 2 weeks after viral injection, whereas very few ND1-transduced cells expressed these markers, even though almost no change was observed in other cell populations, such as GFAP-positive astrocytes, APC-positive oligodendrocytes, and Olig2-positive oligodendrocyte precursor cells ( Figures  7A and 7B) . We performed immunostaining with antibodies for neuronal markers and found that 50% and 33% of ND1-transduced cells were positive for bIII-tubulin and Map2ab, respectively ( Figures 7C and 7D) . Furthermore, when we depleted microglia specifically from the brain by treatment with PLX5622 ( Figures S7A and S7B) , an inhibitor of colony-stimulating factor-1 receptor (Huang et al., 2018) , ND1-reprogrammed DCX-positive cells almost completely disappeared ( Figures  S7C and S7D) . To confirm this result, we employed Rosa-yellow fluorescent protein (YFP) reporter mouse and found that the emergence of DCX and YFP dual-positive cells after lentiviral expression of ND1-P2A-Cre under the control of the CD68 promoter was virtually abolished in the microglia-depleted brain (Figures S7E and S7F ). Taking these observations together, it is most likely that the majority of original cells converted into iN cells by CD68-ND1-P2A-EGFP lentivirus infection were microglia in the striatum. When assessed at 4 weeks after CD68-ND1-P2A-EGFP lentivirus injection, 75% of ND1-transduced cells had become positive for DARPP32, a marker for striatal projection neurons ( Figures 7E and 7F) . These iN cells formed excitatory synapses with host neurons in the striatum ( Figure 7G ). We also performed patch-clamp recordings of iN cells in the striatum ( Figure S7G ). We observed spontaneous action potential firing following depolarization under the current-clamp condition 4 weeks after ND1 transduction ( Figures  S7H and S7I ) and detected spontaneous synaptic events, both excitatory and inhibitory, in iN cells ( Figures S7J-S7M) . These data indicate that ND1 reprograms microglia to striatal projection neuron-like cells in the adult mouse striatum and that these cells are functionally integrated into brain circuits through synaptic connections with other neurons.
DISCUSSION
ND1 has been shown to enable astrocytes to be converted into neurons (Guo et al., 2014) , but the mechanisms involved in this ND1-mediated switch have yet to be determined. Although those authors reported that ND1 failed to induce neuronal reprogramming from microglia, probably because of a low infection efficiency of microglia by the retrovirus (Guo et al., 2014) , we found here that lentivirus-mediated ND1 expression efficiently induces neuronal reprogramming both in vitro and in vivo. Our study further provides a comprehensive description of ND1 occupancy at the initial reprogramming stages and of subsequent transcriptional and epigenetic alterations during neuronal reprogramming. Bivalent genes, characterized by the presence of bivalent domains composed of H3K4me3 and H3K27me3 histone modifications, were initially identified in a subset of key developmentally regulated genes in embryonic stem cells (ESCs) and are thought to prime genes for activation while keeping them repressed (Bernstein et al., 2006; Voigt et al., 2013) . As lineage specification progresses, many bivalent domains are resolved to a monovalently marked state (with either H3K4me3 or H3K27me3) (Mikkelsen et al., 2007) ; however, when assessed in ESC-to-neuron differentiation via NS/PCs, bivalent domains were still observed in neurons because they can be newly formed, even in terminally differentiated cells (Mohn et al., 2008) . In the present study, we demonstrated that neuronal genes in the terminally differentiated microglia retained bivalent domains and that the expression of these genes was suppressed ( Figures 4A and S4D) . ND1 selectively increases the expression of these bivalent genes, although it could bind to H3K4me3-occupied domains regardless of the presence of H3K27me3, suggesting that the bivalent state exists to keep neuronal genes suppressed in microglia and primes these genes for activation at the initial phase of ND1-mediated re- programming. As neuronal reprogramming proceeded, these bivalent domains resolved to a monovalent H3K4me3 state, and this may have contributed to the cells gaining and maintaining neuronal identity. Thus, it is conceivable that the bivalent domains observed in this study behave during ND1-mediated neuronal reprogramming in a manner similar to how they behave in pluripotent cell differentiation.
A comparison of Ascl1-bound sites during reprogramming of mouse embryonic fibroblasts to neurons and specific histone modifications present at these sites revealed the coexistence of a trivalent chromatin state, composed of two marks associated with an active state (monomethylation of histone H3 at lysine 4 [H3K4me1] and acetylation of histone H3 at lysine 27 [H3K27ac]) and a repressive mark (H3K9me3), on many Ascl1bound loci (Wapinski et al., 2013) . Keratinocytes selected by the absence of such a trivalent state at predicted Ascl1 target sites could not be reprogrammed into neurons following Ascl1 transduction (Wapinski et al., 2013) . However, we have shown that ND1, but not Ascl1, can efficiently reprogram microglia to neurons; this is likely because Ascl1 target sites lack such a trivalent state in microglia, although further investigation is warranted. Because ND1 binds to bivalent domains as mentioned above, these findings indicate that the pioneering activity of these two transcription factors relies on distinct patterns of histone modifications at the beginning of reprogramming in the cells.
Suppression of the somatic program has been reported to occur earlier than reactivation of the pluripotency network during reprogramming to iPSCs (Foshay et al., 2012; Koche et al., 2011; Stadtfeld et al., 2008) . In support of this, it has been proposed that actively transcribed genes in somatic cells are relatively accessible to reprogramming factors that can silence them, whereas pluripotency-associated genes are rather inaccessible or are occluded by stably bound repressive complexes (Chronis et al., 2017; Foshay et al., 2012) . In the present study, we have shown that ND1 invokes the neuronal program before the microglial program is extinguished. ND1 directly induces neuronal genes but indirectly silences microglial genes by directly inducing transcriptional repressor genes such as Scrt1 and Meis2, important factors in brain development (Agoston et al., 2014; Itoh et al., 2013) . These findings reveal a stepwise process for the establishment of cell identity during neuronal reprogramming and highlight differences between iPSC and iN cell generation mediated by distinct reprogramming factors.
Reprogramming to iPSCs by transcription factors brings about a global reversion of the somatic epigenome to the pluripotent state for the effective reactivation of pluripotency genes (Chronis et al., 2017; Foshay et al., 2012; Simonsson and Gurdon, 2004) . In neuronal reprogramming from fibroblasts, epigenetic regulators such as Jmjd2d contribute to this process (Wapinski et al., 2013) . In this study, we have shown that forced expression of ND1 in microglia increases H3K27me3 levels and decreases H3K4me3 levels in the promoter regions of microglia-specific genes. Furthermore, ND1 transduction increases DNA methylation levels around enhancer regions for the microglial program. These findings suggest that ND1 instructs reprogramming of the epigenetic landscape to silence microglial cell identity. Because ND1 does not always effectively induce neuronal reprogramming in cells such as non-reactive astrocytes (Brulet et al., 2017) , we believe that future studies (e.g., stepwise analysis of the epigenetic profile and chromatin modifier dynamics during neuronal reprogramming from different types of somatic cells) will yield insights into how and when ND1 achieves the rewriting of the epigenetic landscape.
Taken together, our findings provide insights into how a single neurogenic transcription factor, ND1, mediates transcriptional and epigenetic networks during neuronal reprogramming of microglia and bring us one step closer to developing therapeutic strategies for nerve injury and disease by reprogramming microglia that accumulate at lesion sites into neurons.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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Zhang, Y., Chen, K., Sloan, S.A., Bennett, M.L., Scholze, A.R., O'Keeffe, S., Phatnani, H.P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) . An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929-11947. Zhang, M., Lin, Y.H., Sun, Y.J., Zhu, S., Zheng, J., Liu, K., Cao, N., Li, K., Huang, Y., and Ding, S. (2016) . Pharmacological reprogramming of fibroblasts into neural stem cells by signaling-directed transcriptional activation. Cell Stem Cell 18, 653-667. Zohren, F., Souroullas, G.P., Luo, M., Gerdemann, U., Imperato, M.R., Wilson, N.K., Gö ttgens, B., Lukov, G.L., and Goodell, M.A. (2012) . The transcription factor Lyl-1 regulates lymphoid specification and the maintenance of early T lineage progenitors. Nat. Immunol. 13, 761-769. ICR mice were carefully dissected after stripping of meninges. The tissue was digested with papain (Sigma) at 37 C for 20 min. After centrifugation (200g, 5 min), the cell pellet was suspended in alpha-minimum essential medium (MEM) with 5% fetal bovine serum (FBS) and 0.6% glucose, and the suspension was passed through a 40-mm Cell Strainer (BD Falcon). After centrifugation (200 g, 5 min), the cell pellet was resuspended in DMEM containing 10% FBS and a low concentration of GM-SCF (0.1 ng/ml; PeproTech) to enhance microglial proliferation. These mixed glial cells were plated in T75 tissue culture flasks. The medium was renewed every 2-3 days. Seven days after plating, microglia and OPCs were detached from astrocyte monolayer sheets by shaking for 1 h and then collected and plated onto uncoated 35-mm culture dishes to remove OPCs. After a 30-min incubation, the medium was removed by suction and DMEM containing 10% FBS without GM-SCF (microglial medium) was added to the dish. These primary cultured microglia were used for neuronal conversion. After the shake-off procedure for the isolation of microglia, the cells were treatd with AraC (5 mM) to eliminate proliferating cells for a total of 2 days. Cultures were shaken once more, and then Trypsin EDTA solution was added to the flask to obtain the remaining astrocytes, which were transferred to a 35-mm culture dish and maintained in DMEM containing 10% FBS. Two days after plating, the astrocytes were used for assays. To obtain oligodendrocytes, OPCs were plated in a poly-L-lysine-coated 35-mm culture dish and cultured with DMEM/F12 supplemented with insulin (25 mg/ml), apo-transferrin (100 mg/ml), progesterone (20 nM), putrescine (60 mM), sodium selenite (30 nM), human PDGF-AA (10 ng/ml, Peprotech), bFGF (20 ng/ml, Peprotech) and EGF (20 ng/ml, Peprotech). For oligodendrocyte differentiation, triiodo-L-thyronine (T3; 50 ng/ml, Sigma-Aldrich) and L-thyroxine (T4; 50 ng/ml, Sigma-Aldrich) were added to the medium and cultured for 7 days. Neuronal cultures were prepared from P1 mouse cortex according to a previously described protocol, with some modification (Matsuda et al., 2015) . The cortexes were digested with papain at 37 C for 20 min and triturated with a 1 mL pipette. MEM with 5% FBS and 0.6% glucose was added and the mixture was plated onto a poly-L-lysine-coated 35-mm culture dish. After 3 h, the medium was replaced with maintenance medium (Neurobasal Medium (GIBCO) supplemented with B27 (GIBCO)) containing cytosine b-D-arabinofuranoside (5 mM; Sigma) to eliminate proliferating cells. To avoid neuronal cell death by a complete medium change, half of the medium was replaced every 3 days with fresh maintenance medium.
STAR+METHODS KEY RESOURCES
iN cell induction
To induce iN cells, we used lentiviral vectors that control gene expression under the tetracycline operator. Plasmids for the candidate factors Ascl1, ND1, Brn2, Myt1l, Olig2 and Zic1 were obtained from Addgene. cDNAs for other candidate factors were cloned into the Tet-O-FUW vector using EcoRI sites. Lentivirus vectors used to express short hairpin (sh)RNA for MBD3, miR-124, Lyl1 (Lyl1 sh1 and sh2), Mafb (Mafb sh1 and sh2) and Batf3 (Batf3 sh1 and sh2) were cloned into the pLLX vector, a generous gift from M. E. Greenberg. Lentiviruses were produced by transfecting HEK293T cells with the lentivirus constructs pCMV-VSV-G-RSV-Rev and pCAG-HIVgp using polyethylenimine. Primary cultured microglia were infected with candidate factor-expressing lentivirus constructs together with an M2rtTA-expressing lentivirus construct (Addgene) in microglia medium containing polybrene (8 mg/ml). After 16-20 h in medium containing lentivirus, the medium was replaced with iN medium, which consists of Neurobasal Medium (GIBCO), B27 (GIBCO), BDNF, GDNF, NT3 (10 ng/ml each, Peprotech) and penicillin/streptomycin/fungizone (HyClone). Doxycycline (2 mg/ml) was added only once to this medium to activate expression of the transduced genes. The medium was changed every 2-3 days for the duration of the culture period. To induce specific ND1 expression in microglia, we used lentivirus carrying M2rtTA under the control of the Iba1 promoter, which was provided by K.F. Tanaka (Tanaka et al., 2012) . To induce activation of microglia, LPS (Sigma) was added to the medium for 12 h before lentiviral infections.
Knockdown experiments
To knock down Lyl1, Mafb and Batf3 expression, shRNA for Lyl1 (Lyl1 sh1 and sh2), Mafb (Mafb sh1 and sh2), Batf3 (Batf3 sh1 and sh2) and Brn2 (Brn2 sh1 and sh2) were cloned into pLLX, which had been modified to express EGFP together with a puromycin resistance gene under the ubiquitin-C promoter. Microglia were infected with shRNA-containing lentivirus and treated one day later with puromycin (2 mg/ml; Sigma, P8833) for an additional 3 days.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde and processed for immunostaining. Cells were blocked for 1 h at room temperature (RT) with blocking solution (5% FBS and 0.3% Triton X-100), and incubated for 2 h at RT with one of the following primary antibodies: anti-Iba1 (1:500), anti-GFAP (1:500), anti-bIII-tubulin (1:500), anti-CD11b (1:500), anti-Olig2 (1:500), anti-CD68 (1:500), anti-Nestin (1:500), anti-Map2 (1:500), anti-DCX (1:500), anti-Map2ab (1:500), anti-GFP (1:500), anti-GAD67 (1:500), anti-VGLUT1 (1:500), anti-NeuN (1:500) and anti-PSD95 (1:100). Stained cells were visualized with a fluorescence microscope (Zeiss Axiovert 200M, Zeiss).
EdU labeling and detection
For EdU experiments, 10 mM EdU was added to the culture medium and was maintained throughout medium changes until the cells were fixed. EdU staining was performed using a Click-iT EdU Alexa Fluor 555 Imaging Kit (Life Technologies) according to the supplier's protocol. Stained cells were visualized with a fluorescence microscope (Zeiss Axiovert 200M, Zeiss).
